Suppr超能文献

铁(III)螯合剂作为抗疟药的作用模式。IV. 苯甲酰基和异烟酰腙衍生物对去铁胺作用的增强

Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.

作者信息

Tsafack A, Loyevsky M, Ponka P, Cabantchik Z I

机构信息

Department of Biological Chemistry, Institute of Life Sciences, Hebrew University, Jerusalem, Israel.

出版信息

J Lab Clin Med. 1996 Jun;127(6):574-82. doi: 10.1016/s0022-2143(96)90148-1.

Abstract

The antimalarial action of iron chelators is limited by factors related to drug permeation and parasite susceptibility to metal deprivation. In this study we applied iron-chelating isonicotinoyl and benzoyl hydrazones on Plasmodium falciparum cultures and assessed their antimalarial properties. The agents w ere used both individually and in combination with deferoxamine (DFO), a clinically approved iron chelator, and with hydroxyethyl-starch-DFO, a macromolecular carrier of DFO. Salicylaldehyde isonicotinoyl hydrazone (SIH) and 2-hydroxy-1-naphthylaldehyde m-fluorobenzoyl hydrazone (HNFBH) were found to be highly efficient in suppressing parasite growth at all developmental stages (IC50 24 +/- 6 micromol/L and 0.21 +/- 0.04 micromol/L, respectively, in a 36-to-42 hour test). In combination with impermeant DFO, SIH and HNFBH actions on ring forms were significantly potentiated in terms of speed of drug action and extent of inhibition. The combined effect of the hydrazones with DFO was greater than additive. Based on the capacity of SIH to extract iron from infected cells and to transfer the metal to extracellular DFOs, we propose a mechanism for a synergistic action of permeant hydrazones and impermeant (DFO) iron chelators. The application of a combination of iron chelators as antimalarials might be of therapeutic value.

摘要

铁螯合剂的抗疟作用受到与药物渗透以及寄生虫对金属剥夺的敏感性相关因素的限制。在本研究中,我们将铁螯合异烟酰腙和苯甲酰腙应用于恶性疟原虫培养物,并评估了它们的抗疟特性。这些药剂既单独使用,也与去铁胺(DFO,一种临床批准的铁螯合剂)以及羟乙基淀粉 - DFO(DFO的大分子载体)联合使用。发现水杨醛异烟酰腙(SIH)和2 - 羟基 - 1 - 萘甲醛间氟苯甲酰腙(HNFBH)在抑制所有发育阶段的寄生虫生长方面非常有效(在36至42小时的试验中,IC50分别为24±6微摩尔/升和0.21±0.04微摩尔/升)。与非渗透性DFO联合使用时,SIH和HNFBH对环状体的作用在药物作用速度和抑制程度方面均得到显著增强。腙类与DFO的联合作用大于相加作用。基于SIH从感染细胞中提取铁并将金属转移至细胞外DFO的能力,我们提出了一种渗透性腙类和非渗透性(DFO)铁螯合剂协同作用的机制。联合应用铁螯合剂作为抗疟药可能具有治疗价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验